Ирландия - английски - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - sertraline hydrochloride - film coated tablet - 50 milligram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - sertraline hydrochloride - film coated tablet - 100 milligram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 5 milligram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 10 milligram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 5 milligram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - donepezil hydrochloride - film coated tablet - 10 milligram

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage);  ; cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage) - capsule - 250 mg - active: cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage)   excipient: brilliant blue fcf carmoisine colloidal silicon dioxide croscarmellose sodium gelatin   magnesium stearate methyl hydroxybenzoate   ponceau 4r pregelatinised maize starch propyl hydroxybenzoate   titanium dioxide   water   active: cefaclor monohydrate 267.5mg equivalent to cefaclor 250 mg (plus 2% overage) excipient: brilliant blue fcf carmoisine colloidal silicon dioxide croscarmellose sodium gelatin   magnesium stearate methyl hydroxybenzoate   ponceau 4r pregelatinised maize starch propyl hydroxybenzoate   titanium dioxide   - · lower respiratory infections, including pneumonia caused by s. pneumoniae, h. influenzae (including both ampicillin-sensitive and ampicillin-resistant strains), and s. pyogenes (group a beta- haemolytic streptococci), m.catarrhalis, acute bronchitis, and acute exacerbations of chronic bronchitis. · upper respiratory infections, including pharyngitis and tonsillitis caused by s. pyogenes (group a beta-haemolytic streptococci) and m. catarrhalis. note: penicillin is the usual medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. amoxicillin has been recommended by the american heart association as the standard regimen for the prophylaxis of bacterial endocarditis for dental, oral, and upper respiratory tract procedures, with penicillin v a rational and acceptable alternative in the prophylaxis against beta-haemolytic streptococcal bacteriaemia in this setting. cefaclor is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever or bacterial endocarditis are not available at present.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefaclor monohydrate 535mg equivalent to cefaclor 500 mg (plus 2% overage.) - capsule - 500 mg - active: cefaclor monohydrate 535mg equivalent to cefaclor 500 mg (plus 2% overage.) excipient: brilliant blue fcf carmoisine colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide black magnesium stearate methyl hydroxybenzoate   ponceau 4r pregelatinised maize starch propyl hydroxybenzoate   titanium dioxide  

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefaclor monohydrate 27.8 mg/ml equivalent to cefaclor 25 mg/ml;   - granules for oral suspension - 125 mg/5ml - active: cefaclor monohydrate 27.8 mg/ml equivalent to cefaclor 25 mg/ml   excipient: allura red ac citric acid colloidal silicon dioxide simeticone sodium benzoate sodium citrate dihydrate strawberry flavour 052311 ap0551 sucrose xanthan gum - cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated micro-organisms: lower respiratory infections, including pneumonia caused by s. pneumoniae, h. influenzae (including both ampicillin-sensitive and ampicillin-resistant strains), and s. pyogenes (group a beta- haemolytic streptococci), m.catarrhalis, acute bronchitis, and acute exacerbations of chronic bronchitis. upper respiratory infections, including pharyngitis and tonsillitis caused by s. pyogenes (group a beta-haemolytic streptococci) and m. catarrhalis. otitis media caused by s. pneumoniae, h. influenzae (including both ampicillin-sensitive and ampicillin-resistant strains) staphylococci, and s. pyogenes (group a beta-haemolytic streptococci), and m. catarrhalis. skin and soft-tissue infections caused by staphylococcus aureus (including ?-lactamase producing strains), s. pyogenes (group a beta-haemolytic streptococci) and staphylococcus epidermidis (including ?-lactamase producing strains). urinary tract infections, including pyelonephritis and cystitis caused by e. coli, p, mirabilis, klebsiella sp" and coagulase-negative staphylococci. note: cefaclor has been found to be effective in both acute and chronic urinary tract infections; sinusitis; gonococcal urethritis. skin and skin structure infections caused by staphylococcus aureus and s. pyogenes (group a beta-haemolytic streptococci). sinusitis. gonococcal urethritis, but appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor. therapy may be started while awaiting the results of these studies. once these results become available, antimicrobial therapy should be adjusted accordingly.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefaclor monohydrate 55.6 mg/ml equivalent to cefaclor 50 mg/ml - granules for oral suspension - 250 mg/5ml - active: cefaclor monohydrate 55.6 mg/ml equivalent to cefaclor 50 mg/ml excipient: allura red ac citric acid colloidal silicon dioxide simeticone sodium benzoate sodium citrate dihydrate strawberry flavour 052311 ap0551 sucrose xanthan gum